Ratio Therapeutics

0 followers

‌

A discovery through early clinical phase pharmaceutical company, Ratio Therapeutics employs a suite of innovative technologies to develop best-in-class targeted radiotherapeutics for the treatment of cancer.

Industries

Biotechnology, Pharmaceutical

Headquarters

Boston, United States

Employees

11-50

Links

Org chart

Jack Hoppin

Chairman & CEO

Jack Hoppin

Collapse

John Babich

Director, President, & Chief Scientific Officer

Shawn Hillier

COO

Jacob Hesterman

Chief Data Officer

John M. Garvey

Chief Legal Officer & General Counsel

Matthias Friebe

Chief Technology Officer

Stephen Dimagno

Head, Chemistry

Kelly Orcutt

Head, Pharmacology

Allan Green

Director & Regulatory Consultant

Susan K. Whoriskey

Director

Bill Cupelo

Chief Business Officer

Robyn T.

Financal Operations Specialist

Teams

Scientific Research Team

10 members

Leadership Team

8 members

Operations Team

5 members

Data and Technology Team

4 members

Similar companies

Elicio Therapeutics

1 follower

Artiva Biotherapeutics

1 follower

ByHeart

2 followers

AbbVie

169 followers

Cytokinetics

11 followers

Capricor Therapeutics

1 follower

Neurocrine Biosciences

5 followers

Coherus BioSciences

5 followers

Pfizer

471 followers

SmithRx

4 followers

KIA

2 followers

Explore companies